NCT06608238: An ongoing trial by SkinJect, Inc.
This trial is ongoing. It must report results 7 months, 3 weeks from now.
Full data
| Full entry on ClinicalTrials.gov | NCT06608238 |
|---|---|
| Title | A Randomized, Double-Blinded, Placebo Controlled Trial to Evaluate the Safety and Efficacy of a Doxorubicin Microneedle Array (D-MNA) for the Treatment of Nodular Basal Cell Carcinoma in Adults |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Sept. 3, 2024 |
| Completion date | Feb. 5, 2025 |
| Required reporting date | Feb. 5, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | June 17, 2025 |
| Days late | None |